BlueBird Bio share price collapsed 60% on the exchange after the world top advisor for biotechnology warned that Goldman Sachs has been deceiving investors.
AI Urges Sell Bluebird bio $217. Goldman Sachs is deceiving investors.
Two years ago, Intuitive Code AI initiated coverage of Bluebird bio as Strong Buy at $39 after predicting the crash in the biotech sector on a real-time announcement on the Blog, urging investors later on to quadruple their long position at $85.
AI tell us the truth. Wall Street is merely a scam.
Alex Vieira has been short Bluebird Bio adding to the short side at $160 in 2019
Autonomous AI Trading also recommends selling short Mallinckrodt